Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

8DHM

Human TMEM175 in complex with 4-aminopyridine

Summary for 8DHM
Entry DOI10.2210/pdb8dhm/pdb
EMDB information27436
DescriptorEndosomal/lysosomal potassium channel TMEM175, POTASSIUM ION, 4-AMINOPYRIDINE, ... (4 entities in total)
Functional Keywordspotassium channel, ion channel, transport protein
Biological sourceHomo sapiens (human)
Total number of polymer chains2
Total formula weight111585.95
Authors
Oh, S.,Hite, R.K. (deposition date: 2022-06-27, release date: 2022-11-23, Last modification date: 2024-06-12)
Primary citationOh, S.,Stix, R.,Zhou, W.,Faraldo-Gomez, J.D.,Hite, R.K.
Mechanism of 4-aminopyridine inhibition of the lysosomal channel TMEM175.
Proc.Natl.Acad.Sci.USA, 119:e2208882119-e2208882119, 2022
Cited by
PubMed Abstract: Transmembrane protein 175 (TMEM175) is an evolutionarily distinct lysosomal cation channel whose mutation is associated with the development of Parkinson's disease. Here, we present a cryoelectron microscopy structure and molecular simulations of TMEM175 bound to 4-aminopyridine (4-AP), the only known small-molecule inhibitor of TMEM175 and a broad K channel inhibitor, as well as a drug approved by the Food and Drug Administration against multiple sclerosis. The structure shows that 4-AP, whose mode of action had not been previously visualized, binds near the center of the ion conduction pathway, in the open state of the channel. Molecular dynamics simulations reveal that this binding site is near the middle of the transmembrane potential gradient, providing a rationale for the voltage-dependent dissociation of 4-AP from TMEM175. Interestingly, bound 4-AP rapidly switches between three predominant binding poses, stabilized by alternate interaction patterns dictated by the twofold symmetry of the channel. Despite this highly dynamic binding mode, bound 4-AP prevents not only ion permeation but also water flow. Together, these studies provide a framework for the rational design of novel small-molecule inhibitors of TMEM175 that might reveal the role of this channel in human lysosomal physiology both in health and disease.
PubMed: 36279431
DOI: 10.1073/pnas.2208882119
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.73 Å)
Structure validation

247536

PDB entries from 2026-01-14

PDB statisticsPDBj update infoContact PDBjnumon